HK1259001A1 - 癌症的預後和診斷方法 - Google Patents

癌症的預後和診斷方法

Info

Publication number
HK1259001A1
HK1259001A1 HK19101487.7A HK19101487A HK1259001A1 HK 1259001 A1 HK1259001 A1 HK 1259001A1 HK 19101487 A HK19101487 A HK 19101487A HK 1259001 A1 HK1259001 A1 HK 1259001A1
Authority
HK
Hong Kong
Prior art keywords
prognosis
diagnosis
cancer
methods
Prior art date
Application number
HK19101487.7A
Other languages
English (en)
Inventor
Koshikawa Naohiko
Nakagawa Masatoshi
Yoshida Eisaku
Yoshimura Toru
Seiki Motoharu
Original Assignee
雅培日本有限公司
國立大學法人東京大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50066470&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1259001(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 雅培日本有限公司, 國立大學法人東京大學 filed Critical 雅培日本有限公司
Publication of HK1259001A1 publication Critical patent/HK1259001A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK19101487.7A 2012-08-13 2019-01-29 癌症的預後和診斷方法 HK1259001A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261682462P 2012-08-13 2012-08-13
US13/962,494 US20140045196A1 (en) 2012-08-13 2013-08-08 Methods of prognosis and diagnosis of cancer

Publications (1)

Publication Number Publication Date
HK1259001A1 true HK1259001A1 (zh) 2019-11-22

Family

ID=50066470

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15112178.2A HK1211345A1 (zh) 2012-08-13 2015-12-10 癌症的預後和診斷方法
HK19101487.7A HK1259001A1 (zh) 2012-08-13 2019-01-29 癌症的預後和診斷方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15112178.2A HK1211345A1 (zh) 2012-08-13 2015-12-10 癌症的預後和診斷方法

Country Status (5)

Country Link
US (1) US20140045196A1 (zh)
JP (1) JP6328103B2 (zh)
CN (2) CN104755935B (zh)
HK (2) HK1211345A1 (zh)
WO (1) WO2014027701A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170089905A1 (en) * 2015-09-28 2017-03-30 Abbott Japan Co., Ltd. Methods of diagnosing hepatocellular carcinoma and pancreatic cancer
RU2018127709A (ru) * 2016-01-22 2020-02-25 Отрэйсис, Инк. Системы и способы улучшения диагностики заболеваний
BR112018067990A2 (pt) * 2016-03-09 2019-02-05 Cezanne S A S cromogranina a como um marcador para câncer de bexiga
CN109486948A (zh) * 2018-10-16 2019-03-19 温州医科大学 一种功能驱动的个体化预测结直肠癌预后的多分子标志物及其装置与评价方法
CN113287013A (zh) * 2019-01-04 2021-08-20 国立大学法人京都大学 溃疡性大肠炎以及原发性硬化性胆管炎的检查方法
US20230340580A1 (en) * 2020-02-25 2023-10-26 The University Of Tokyo LAMC2-NR6A1 Splicing Variant and Translation Product Thereof
CN113495159A (zh) * 2020-03-20 2021-10-12 郑州达诺生物技术有限公司 一种***反应液、一种25羟基维生素d定量检测试剂盒及其使用方法
WO2023008329A1 (ja) * 2021-07-26 2023-02-02 国立大学法人東京大学 細胆管増生を伴う肝細胞を検出するためのバイオマーカー
EP4357782A1 (en) * 2022-10-18 2024-04-24 MU Bioteknik Aktiebolag Protein biomarker panel for the diagnosis of colorectal cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955924B2 (en) * 1994-10-04 2005-10-18 Biostratum, Inc. Laminin chains: diagnostic uses
US5660982A (en) * 1994-10-04 1997-08-26 Tryggvason; Karl Laminin chains: diagnostic uses
DE19701607A1 (de) * 1997-01-17 1998-07-23 Hoechst Ag Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung
WO2001087239A2 (en) * 2000-05-12 2001-11-22 Fibrogen, Inc. Methods of affecting laminin 5 processing
FR2826292B1 (fr) * 2001-06-22 2004-01-23 Rhodia Chimie Sa Emulsions huile dans huile comprenant une silicone, dispersions de telles emulsions et utilisation
US20040076955A1 (en) * 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
WO2003016907A1 (fr) * 2001-08-17 2003-02-27 Eisai Co. Ltd. Reactif de dosage pour antigene de la laminine 5 dans un echantillon biologique et procede de dosage
EP1578444A2 (en) * 2002-10-29 2005-09-28 Sirpa Salo Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis
EP1723428A2 (en) * 2004-02-19 2006-11-22 Yale University Corporation Identification of cancer protein biomarkers using proteomic techniques
US20100003704A1 (en) * 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
US20110312511A1 (en) * 2007-02-27 2011-12-22 Ola Winquist Multiplex Detection of Tumour Cells Using a Panel of Agents Binding to Extracellular Markers
JP5754844B2 (ja) * 2010-03-09 2015-07-29 国立大学法人 東京大学 泌尿器科がんの検査方法及び検査用キット
EP2668508A2 (en) * 2011-01-27 2013-12-04 Virginia Commonwealth University Diagnostic and prognostic markers for metastasis
CN102621307B (zh) * 2012-03-12 2014-04-30 沈周俊 尿层粘连蛋白在制备诊断膀胱癌的医疗器械中的应用

Also Published As

Publication number Publication date
US20140045196A1 (en) 2014-02-13
JP6328103B2 (ja) 2018-05-23
JP2015527562A (ja) 2015-09-17
WO2014027701A1 (en) 2014-02-20
CN104755935B (zh) 2018-03-20
CN108469523A (zh) 2018-08-31
HK1211345A1 (zh) 2016-05-20
CN104755935A (zh) 2015-07-01

Similar Documents

Publication Publication Date Title
HK1259001A1 (zh) 癌症的預後和診斷方法
IL276300A (en) GRPR antagonists for the detection, diagnosis and treatment of GRPR-positive cancer
HK1206431A1 (zh) 癌症轉移的預後和治療方法
EP2890815A4 (en) METHOD FOR THE DIAGNOSIS AND TREATMENT OF CANCER
HK1212256A1 (zh) 抗- 抗體及相關使用方法
GB201320061D0 (en) Materials nad methods for diagnosis and prognosis of liver cancer
GB2513275B (en) Biomarkers for Breast Cancer Prediction and Diagnosis
EP2867376A4 (en) TARGETED METHODS KNOWN AS RNA-SEQ AND MATERIALS FOR THE DIAGNOSIS OF PROSTATE CANCER
EP2707710A4 (en) DIAGNOSIS OF CANCER
EP2888370A4 (en) DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
HK1215000A1 (zh) 結腸癌的治療和診斷
HK1213634A1 (zh) 檢測癌症的方法
EP2903644A4 (en) TREATMENT OF CANCER
HK1205254A1 (zh) 治療癌症的方法
HK1205558A1 (zh) 用於宮頸癌的檢測和預後的方法和生物標誌物
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
IL244632A0 (en) Cancer biomarker and diagnostics
EP2880443A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECAST IN BREAST CANCER
EP2817011A4 (en) TREATMENT OF CANCER
GB201412831D0 (en) Detection and treatment of breast cancer
EP2709730A4 (en) TREATMENT AND PROGNOSIS OF CANCER
EP2812694A4 (en) TESTS AND METHODS FOR DIAGNOSING OVARIAN CANCER
HK1213584A1 (zh) 用於治療癌症的 抗體及方法
EP2732287A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
EP2576610A4 (en) BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF DARM CANCER